Vivoryon Therapeutics N.V.
Hieronder vindt u informatie uit het register openbaarmaking voorwetenschap. Deze informatie is door de organisatie verstrekt.
Publicatie datum
09 jun 2016 - 07:45
Statutaire naam
Vivoryon Therapeutics N.V.
Titel
Probiodrug:Two key patents on Glutaminyl Cyclase (QC) inhibition for the treatment of Alzheimer's disease (AD) granted in Japan
Bericht
Two key patents on Glutaminyl Cyclase (QC) inhibition for the treatment of Alzheimer's disease (AD) granted in Japan
Patent grants cover Probiodrug's lead QC inhibitor PQ912, for treatment of AD and the use of QC inhibition for treatment of mild cognitive impairment (MCI)
Strengthens IP position in Japan and complements grants obtained in other key markets
Gerelateerde downloads
Datum laatste update: 08 januari 2026